AJP - Endo Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 274: E758-E771, 1998;
0193-1849/98 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rostami-Hodjegan, A.
Right arrow Articles by Tucker, G. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rostami-Hodjegan, A.
Right arrow Articles by Tucker, G. T.
Vol. 274, Issue 4, E758-E771, April 1998

MODELING IN PHYSIOLOGY
Population-based modeling to demonstrate extrapancreatic effects of tolbutamide

A. Rostami-Hodjegan1, S. R. Peacey2, E. George2, S. R. Heller3, and G. T. Tucker1

1 Department of Medicine and Pharmacology, University of Sheffield, The Royal Hallamshire Hospital, Sheffield S10 2JF; and 2 University Department of Medicine, Clinical Sciences Centre, and 3 Diabetic Centre, Northern General Hospital, Sheffield S5 7AU, United Kingdom

Tolbutamide is used increasingly as an investigative tool in in vivo studies of the physiology of glucose tolerance. Its hypoglycemic effect in nondiabetic subjects is widely variable, reflecting possible variability in its pharmacokinetics, an insulinergic response, an extrapancreatic effect of the drug, or the hypoglycemic effect of insulin itself. Using population-based modeling, we have investigated the kinetics and dynamics of tolbutamide and assessed covariates in two groups of healthy subjects. The results indicate a high variability in insulinergic effect, measured by the area under of the curve of insulin (0-60 min), in response to tolbutamide injection (coefficient of variation = 29-96%). However, it appears that impaired insulin sensitivity is compensated by higher insulin secretion in response to tolbutamide. Thus the hypoglycemic effect of high insulin secretion is minimal in insulin-resistant subjects. Application of the model indicated that tolbutamide has appreciable extrapancreatic effects mediated by prolongation of the residence time of insulin in a remote effect and by enhancement of glucose effectiveness. An effect in increasing the insulin sensitivity index is also possible but could not be confirmed statistically for all groups of subjects studied. These observations may explain inconsistencies between the results of tolbutamide and insulin injection in the frequently sampled intravenous glucose tolerance test and call for further study of insulin- vs. tolbutamide-modified frequently sampled intravenous glucose tolerance tests in the assessment of the insulin sensitivity and glucose effectiveness indexes.

insulin secretion; insulin sensitivity; population pharmacokinetics-pharmacodynamics; sulfonylureas; minimal model


This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
I. F. Godsland, O. F. Agbaje, and R. Hovorka
Evaluation of nonlinear regression approaches to estimation of insulin sensitivity by the minimal model with reference to Bayesian hierarchical analysis
Am J Physiol Endocrinol Metab, July 1, 2006; 291(1): E167 - E174.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
P. Vicini and C. Cobelli
The iterative two-stage population approach to IVGTT minimal modeling: improved precision with reduced sampling
Am J Physiol Endocrinol Metab, January 1, 2001; 280(1): E179 - E186.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A. Caumo, P. Vicini, J. J. Zachwieja, A. Avogaro, K. Yarasheski, D. M. Bier, and C. Cobelli
Undermodeling affects minimal model indexes: insights from a two-compartment model
Am J Physiol Endocrinol Metab, June 1, 1999; 276(6): E1171 - E1193.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online